Impact of the COVID-19 Pandemic on Door-to-Device Time Segments and Clinical Outcomes for STEMI Patients in Northern

San-Fang Chou1, Chun-Yu Hsieh2, Kuang-Chau Tsai3

  • 1Department of Medical Research.

Acta Cardiologica Sinica
|January 8, 2025
PubMed

Insights

The COVID-19 pandemic prolonged Door-to-Device times for ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (pPCI). However, clinical outcomes remained stable, showcasing healthcare system resilience.

Area of Science:

  • Cardiology
  • Public Health
  • Healthcare Management

Background:

  • Primary percutaneous coronary intervention (pPCI) is vital for ST-segment elevation myocardial infarction (STEMI) patients.
  • The COVID-19 pandemic significantly impacted healthcare delivery globally.
  • This study investigates the pandemic's effects on pPCI procedures and outcomes in STEMI patients.

Purpose of the Study:

  • To assess the impact of the COVID-19 pandemic on Door-to-Device (DTD) times for pPCI in STEMI patients.
  • To analyze changes in specific DTD time segments during different pandemic phases.
  • To evaluate the influence of the pandemic on clinical outcomes of STEMI patients undergoing pPCI.

Main Methods:

  • Retrospective, single-center study of STEMI patients undergoing pPCI (February 2019 - January 2022).
  • Categorization of the pandemic into three periods: pre-COVID-19, early-pandemic, and epidemic.
  • Analysis of DTD time, its components, and clinical outcomes using SPSS.

Main Results:

  • Door-to-electrocardiogram (ECG), ECG-to-Cardiac Catheterization Laboratory Activation (CCLA), and CCLA-to-Lab Door times increased in the epidemic period (Period-III).
  • Angio-to-Device time decreased during the early-pandemic (Period-II) and epidemic (Period-III) phases.
  • Overall DTD time increased in Period-III, but decreased in Period-II. Odds of achieving DTD ≤ 90 minutes decreased by 70% in Period-III.
  • Despite DTD time changes, key clinical outcomes (ICU stay, hospital stay, mortality, readmission) remained stable.

Conclusions:

  • The COVID-19 pandemic differentially affected segments of the pPCI workflow, influenced by infection control and clinical adaptations.
  • The healthcare system demonstrated resilience, maintaining stable clinical outcomes for STEMI patients despite pandemic-related procedural challenges.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
891
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
954
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
500
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
525
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
625